Asked Oct 28, 10:16 AM EDT (morning session). Perplexity, Muse Spark 1.1, Grok 4.7, GPT-5.1, DeepSeek, GPT-6, Claude Sonnet 5.5 and Gemini 3.6 Flash High answered the same standard prompt independently. Window: from Oct 28, 10:16 AM EDT to Oct 29, 10:16 AM EDT, the same time one session later. Benchmark: SPY.
Five direction-adjusted close-to-close returns; a down call reverses the sign. The score is the mean signed return, without subtracting the benchmark. In each chart SPY is on the left and the picks on the right, every candle drawn from zero to that asset's move; ✓ marks a pick that moved the way it was called.
| Model | Correct | Hit rate | Return | SPY | Directional return |
|---|---|---|---|---|---|
| Perplexity | 4/5 | 80.00% | 2.90% | -0.29% | 2.90% |
| Muse Spark 1.1 | 2/5 | 40.00% | -1.30% | -0.29% | -1.30% |
| Grok 4.7 | 2/5 | 40.00% | 0.71% | -0.29% | 0.71% |
| GPT-5.1 | 3/5 | 60.00% | 2.07% | -0.29% | 2.07% |
| DeepSeek | 3/5 | 60.00% | 2.07% | -0.29% | 2.07% |
| GPT-6 | 4/5 | 80.00% | 3.39% | -0.29% | 3.39% |
| Claude Sonnet 5.5 | 3/5 | 60.00% | -0.22% | -0.29% | -0.22% |
| Gemini 3.6 Flash High | 5/5 | 100.00% | 1.50% | -0.29% | 1.50% |
Perplexity
View full picks and reasoning
US equities are in an earnings-driven, high-dispersion session ahead of the Federal Reserve decision and Microsoft and Alphabet results. Substantive earnings surprises are dominating intraday moves: Vertiv and Wendy's are rising on company-specific positive news, while Enphase and F5 are falling on weak results or guidance. I favor continuation for moves backed by hard catalysts, with the main risk that extreme opening moves mean-revert later in the session.
- VRT up — confidence 68%. Vertiv is the strongest substantive continuation candidate: it reported Q3 net sales of $4.31 billion versus roughly $3.76 billion consensus, adjusted EPS of $2.21 versus $1.82 expected, and raised full-year 2026 guidance. The move is earnings-driven rather than speculative, and the stock's large market cap and heavy session turnover support tradability. I used the live intraday quote of $238.81, up 14.50% in the source session; the 20-day average dollar volume could not be independently verified, so that field is omitted, although the session's multi-million-share volume indicates liquidity far above the $20 million threshold. Risk: a 14%-plus intraday gain can fade if the broader AI-infrastructure trade weakens into the Fed decision.
Return: 3.70%; alpha: 3.99%. - WEN up — confidence 62%. Wendy's surged after Trian Fund Management reportedly offered $7.35 per share in cash, valuing the company at about $1.4 billion. This is a substantive, company-specific takeover catalyst rather than a technical move, and the offer price sits above the intraday quote, giving the shares a visible anchor. I used the live intraday quote of $7.12, up 15.99% in the source session. Market cap was verified at about $1.34 billion and the price is above $5; the 20-day average dollar volume could not be independently verified, so that field is omitted, though intraday volume of more than 9 million shares implies dollar turnover near $65 million. Risk: deal uncertainty, regulatory or financing conditions, and a possible fade if investors doubt the offer will lead to a definitive agreement.
Return: -0.37%; alpha: -0.08%. - ENPH down — confidence 60%. Enphase is a substantive downside continuation candidate after reporting Q3 revenue of $293.3 million, down from $410.4 million a year earlier, alongside results and guidance that disappointed investors; premarket reports showed the shares down more than 15%. The negative catalyst is fundamental, and the stock remains above the $5 price floor with a verified market cap near $3.88 billion. I used the live intraday quote of $25.43, down 14.57% in the source session; the 20-day average dollar volume could not be independently verified and is omitted, although intraday volume above 9.5 million shares indicates very large dollar turnover. Risk: solar stocks are volatile and a deeply oversold name can bounce sharply once the initial earnings selling exhausts.
Return: -0.80%; alpha: 1.09%. - FFIV down — confidence 58%. F5 is a substantive downside continuation candidate: it beat fiscal Q4 expectations but issued a fiscal 2027 outlook that disappointed investors, and Piper Sandler downgraded the shares to Neutral. The move is guidance-driven rather than purely speculative. I used the live intraday quote of $389.84, down 15.13% in the source session; market cap was verified near $26.01 billion and the stock easily clears the price and market-cap floors. The 20-day average dollar volume could not be independently verified, so that field is omitted, but the company's size and normal trading activity indicate the $20 million threshold is very likely met. Risk: after a 15% decline, value buyers may attempt a reversal, particularly if the broader software complex stabilizes.
Return: -3.61%; alpha: 3.91%. - AXGN up — confidence 45%. Axogen is the fifth source-session extreme mover, trading near $45.68, up 21.95% intraday, with a market cap of about $2.20 billion, satisfying the price and market-cap floors. I could not verify a specific same-day company catalyst or the 20-day average dollar volume from the available sources, so the catalyst is treated as speculative and the dollar-volume field is omitted rather than guessed. The continuation thesis is therefore weaker and confidence is lower: a 22% intraday advance without a clearly confirmed fundamental catalyst is prone to intraday mean reversion. Risk: if the move is driven by a transient news item or short covering, the next-session close could readily reverse.
Return: 6.76%; alpha: 7.05%.
Muse Spark 1.1
View full picks and reasoning
October 28 2026 session is earnings-driven with wide dispersion. Large-cap AI infrastructure names are beating and raising guidance while aerospace and legacy tech are missing on production and outlook. S&P 500 +0.1% and Nasdaq +0.4% intraday with advancers edging decliners. Top movers are substantive earnings catalysts, not speculative memes, so momentum may carry but overbought gainers risk intraday profit-taking and oversold losers risk bounce. Overall bias is selective continuation for strong beats, reversal for panic selloffs on mixed results.
- VRT up — confidence 75%. Ranked #7 top gainer Oct 28 on MetaCap list at +13.82% to $237.40 intraday from prior close $208.56. Catalyst is substantive: Q3 2026 earnings beat $2.21 vs $1.82 consensus (+21.43% surprise), revenue $4.31B +61% YoY vs guide, organic orders doubled, full-year guidance raised by $650M. Sources: Zacks reports earnings beat and MarketBeat confirms Oct 28 earnings date. Reference price is delayed intraday quote Oct 28 10:18 AM EDT, freshest available at answer time, not yesterday close. Market cap $91.39B and avg daily traded value $1.60B both exceed $1B and $20M floors. Thesis: continuation up as AI data center infrastructure demand accelerating, CEO citing largest buildout. Risk: valuation at ~55x PE and overbought after 16% premarket move.
Return: 3.70%; alpha: 3.99%. - SOFI up — confidence 70%. Best performer among 42 large caps tracked on AgentFlare Oct 28 at +13.69% to $16.44. Catalyst is substantive: Q3 2026 record revenue $1.39B (+44% YoY) vs $1.28B expected, EPS $0.18 vs $0.17, adjusted EBITDA $470M, raised 2026 guidance to $5.04B revenue and $0.61 EPS and introduced 2027 guidance $6.4B revenue. Sources: ABC Money, TalkMarkets, and The Distributed report Oct 28 surge. Reference price is intraday regular session Oct 28 from AgentFlare list. Market cap $21.17B from same list exceeds floor. Avg daily traded value $1.26B from Finnhub exceeds floor. Thesis: continuation up on guidance raise and cross-sell growth. Risk: still down -37% YTD and resistance at $16.75, profit-taking possible.
Return: 2.70%; alpha: 3.00%. - AXGN down — confidence 60%. Ranked #2 top gainer Oct 28 on MetaCap at +22.61% to $45.93 from prior close $37.46. Catalyst is substantive: Q3 2026 revenue $75.8M +26.2% YoY, EPS $0.21 vs $0.14 consensus +50% surprise, maintained 2026 outlook at least $290M. Sources: Zacks reports beat, Seeking Alpha and GlobeNewswire confirm results Oct 28. Reference price is current price from Finnhub matching MetaCap intraday. Market cap $2.69B from MetaCap exceeds floor. Avg daily traded value $41.84M from Finnhub exceeds floor. Thesis: reversal down as small-cap surgical solutions stock shows 30.33% 5-day return and may face profit-taking after sharp move despite beat. Risk: continued momentum on raised estimates could extend rally.
Return: 6.76%; alpha: -6.47%. - BA down — confidence 68%. Worst performer among 42 large caps on AgentFlare Oct 28 at -10.55% to $168.45, closed prior day Oct 27 at $168.18 down -10.69% per Finnhub. Catalyst is substantive: Q3 2026 revenue $24.19B vs $24.39B consensus, loss -$0.34 vs -$0.255 expected, production delays push 737 ramp to 2027, worst day since June 2020, free cash flow cut to ~$2B. Sources: OQLIV, AeroHaber, and FX Leaders report crash on earnings miss. Reference price is regular session price from AgentFlare list Oct 28, intraday low $165.01, freshest available. Market cap $132.93B and avg daily traded value $1.54B from Finnhub exceed floors. Thesis: continuation down as confidence eroded and backlog execution risk persists. Risk: oversold bounce after hitting 52-week low since May 2025.
Return: 2.55%; alpha: -2.26%. - FFIV up — confidence 62%. Ranked #3 top loser Oct 28 on MetaCap at -16.75% to $382.40 from prior close $459.36. Catalyst is substantive but mixed: Q4 2026 EPS $4.42 beat $4.26 by $0.16 (+4.3%), revenue +13% with systems +29% and AI bookings >$100M, but outlook disappointed investors plus $1.5B buyback announced Oct 27. Sources: Zacks reports earnings beat with systems growth, MarketBeat and The Markets Daily report buyback. Reference price is intraday price from MetaCap losers list Oct 28 10:18 AM EDT. Market cap $21.65B from MetaCap exceeds floor. Avg daily traded value $258.01M from Finnhub exceeds floor. Thesis: reversal up as selloff on guidance may be overdone given beat, AI momentum, and buyback support. Risk: further guidance cuts could drive continuation down.
Return: -3.61%; alpha: -3.32%.
Grok 4.7
View full picks and reasoning
October 27 session featured earnings-driven extremes, with strong beats in equipment rental and biotech lifting select names while guidance cuts and production delays pressured water infrastructure and aerospace; energy refiners also weakened on softer oil. Expect some directional follow-through on the largest liquid moves into the Fed decision day, though overall market remains mixed.
- HRI up — confidence 68%. Ranked among the largest liquid gainers on October 27 after a substantial Q3 earnings beat and raised outlook, with the stock closing up 22.76% at 156.06. Catalyst is substantive (confirmed earnings and guidance). Hypothesis is continuation of the upward move. Latest available quote around 164.29 on the open of October 28 (intraday, roughly 20-30 minutes into the session); market cap confirmed near 5.22 billion and 20-day average share volume near 719 thousand implies dollar volume well above 20 million. Source data from stockanalysis.com and related quote pages.
Return: 3.43%; alpha: 3.73%. - KNSA up — confidence 65%. Among top liquid gainers on October 27 after a strong Q3 beat-and-raise on ARCALYST revenue, closing up 22.23% at 89.20. Catalyst is substantive (earnings and guidance). Hypothesis is continuation of the upward move. Reference price is the October 27 regular close of 89.20 (most consistently confirmed figure; premarket prints near 87.5 were available but not used as the primary quote); market cap near 6.96 billion and average volume supports the dollar-volume threshold. Source from stockanalysis.com.
Return: 8.33%; alpha: 8.63%. - INOD down — confidence 70%. Largest liquid decliner on October 27, falling 25.32% to close at 44.74 amid reports of significant layoffs in India and the Philippines. Catalyst is substantive (operational news impacting the AI data services business). Hypothesis is continuation of the downward move. Latest confirmed quote near 44.22 around 10:03 AM EDT on October 28 (intraday, market open); market cap near 1.52 billion and 20-day average volume of about 1.51 million shares implies dollar volume above 60 million. Source from stockanalysis.com.
Return: 4.08%; alpha: -3.78%. - XYL down — confidence 66%. One of the largest S&P 500 losers on October 27 after an earnings miss and full-year guidance cut tied to deferred utility spending, closing down 14.21% at 92.86. Catalyst is substantive (earnings and outlook). Hypothesis is continuation of the downward move. Latest available quote near 88.00 around 10:10 AM EDT on October 28 (intraday); market cap near 20.3-21.4 billion and average volume well above the dollar threshold. Source from stockanalysis.com and Yahoo Finance.
Return: 1.59%; alpha: -1.30%. - BA down — confidence 64%. Major loser on October 27 after Q3 results missed adjusted EPS expectations and management delayed the 737 production rate target into 2027 with slower cash-flow recovery, closing down 10.69% at 168.18. Catalyst is substantive (earnings and production guidance). Hypothesis is continuation of the downward move. Latest confirmed quote near 166.53 around 10:14 AM EDT on October 28 (intraday); market cap near 132 billion and average volume of roughly 9 million shares implies extremely high dollar volume. Source from stockanalysis.com.
Return: 2.55%; alpha: -2.26%.
GPT-5.1
View full picks and reasoning
US equities are digesting a heavy earnings cycle. Tuesday's session featured sharp idiosyncratic moves in industrials, healthcare and energy, while semiconductor and digital-infrastructure names attracted dip-buyers. Wednesday's intraday tape shows consolidation rather than broad risk-off, favouring continuation of strong earnings-driven trends and further pressure on names with disappointing guidance.
- HRI up — confidence 65%. Herc Holdings closed the 27-Oct source session up 22.76% at $156.06 after a clear Q3 beat and a raised full-year outlook. The catalyst is substantive (record rental revenue, EPS $3.91 vs $2.92 consensus). Intraday on 28-Oct the stock is holding near $156.25, suggesting the market is digesting gains rather than reversing. Strong earnings-driven momentum usually carries into the next session. Market cap $5.05B and 20-day average dollar volume roughly $94M (based on ~600K average shares) both clear the floors. Reference price is a 28-Oct intraday quote.
Return: 3.43%; alpha: 3.73%. - BA down — confidence 60%. Boeing fell 10.75% on 27-Oct to $168.07 after a Q3 loss and a cut to its full-year aircraft delivery target. The catalyst is substantive and negative, and the stock remains under pressure intraday on 28-Oct at about $166.62 (-0.9%). Post-earnings weakness of this magnitude often sees follow-through selling as analysts revise models. Market cap and 20-day average dollar volume could not be precisely verified from available sources, so those fields are omitted rather than guessed. Reference price is a 28-Oct intraday quote.
Return: 2.55%; alpha: -2.26%. - XYL down — confidence 70%. Xylem dropped 14.21% on 27-Oct to $92.86 after missing Q3 revenue estimates and lowering full-year guidance. The negative catalyst is substantive, and the stock is extending losses intraday on 28-Oct at about $91.01. Guidance cuts typically weigh on shares for more than one session. Market cap is $25.27B and 20-day average dollar volume is roughly $200M, comfortably above the floors. Reference price is a 28-Oct intraday quote.
Return: 1.59%; alpha: -1.30%. - KNSA up — confidence 65%. Kiniksa Pharmaceuticals surged 22.23% on 27-Oct to $89.20 after a Q3 earnings beat and raised FY26 sales guidance. The catalyst is substantive (EPS $0.56 vs $0.37 consensus), and the stock is holding those gains intraday on 28-Oct near $89.40. Strong biotech earnings reactions often extend into the following session as new buyers step in. Market cap is approximately $2.74B and 20-day average dollar volume is roughly $45M, both above the required minimums. Reference price is a 28-Oct intraday quote.
Return: 8.33%; alpha: 8.63%. - SOFI up — confidence 60%. SoFi Technologies rose 13.42% on 27-Oct to $16.40 after better-than-expected Q3 results and raised FY26 guidance. The earnings beat is a substantive catalyst, and the stock is consolidating those gains intraday on 28-Oct around $16.43. Profit-momentum stories in fintech tend to attract follow-through buying after a breakout session. Market cap is approximately $18B and 20-day average dollar volume is roughly $866M, well above the floors. Reference price is a 28-Oct intraday quote; market-cap figure is an estimate and therefore not reported as a precise field.
Return: 2.70%; alpha: 3.00%.
DeepSeek
View full picks and reasoning
US equities are digesting a heavy earnings cycle. Tuesday's session featured sharp idiosyncratic moves in industrials, healthcare and energy, while semiconductor and digital-infrastructure names attracted dip-buyers. Wednesday's intraday tape shows consolidation rather than broad risk-off, favouring continuation of strong earnings-driven trends and further pressure on names with disappointing guidance.
- HRI up — confidence 65%. Herc Holdings closed the 27-Oct source session up 22.76% at $156.06 after a clear Q3 beat and a raised full-year outlook. The catalyst is substantive (record rental revenue, EPS $3.91 vs $2.92 consensus). Intraday on 28-Oct the stock is holding near $156.25, suggesting the market is digesting gains rather than reversing. Strong earnings-driven momentum usually carries into the next session. Market cap $5.05B and 20-day average dollar volume roughly $94M (based on ~600K average shares) both clear the floors. Reference price is a 28-Oct intraday quote.
Return: 3.43%; alpha: 3.73%. - BA down — confidence 60%. Boeing fell 10.75% on 27-Oct to $168.07 after a Q3 loss and a cut to its full-year aircraft delivery target. The catalyst is substantive and negative, and the stock remains under pressure intraday on 28-Oct at about $166.62 (-0.9%). Post-earnings weakness of this magnitude often sees follow-through selling as analysts revise models. Market cap and 20-day average dollar volume could not be precisely verified from available sources, so those fields are omitted rather than guessed. Reference price is a 28-Oct intraday quote.
Return: 2.55%; alpha: -2.26%. - XYL down — confidence 70%. Xylem dropped 14.21% on 27-Oct to $92.86 after missing Q3 revenue estimates and lowering full-year guidance. The negative catalyst is substantive, and the stock is extending losses intraday on 28-Oct at about $91.01. Guidance cuts typically weigh on shares for more than one session. Market cap is $25.27B and 20-day average dollar volume is roughly $200M, comfortably above the floors. Reference price is a 28-Oct intraday quote.
Return: 1.59%; alpha: -1.30%. - KNSA up — confidence 65%. Kiniksa Pharmaceuticals surged 22.23% on 27-Oct to $89.20 after a Q3 earnings beat and raised FY26 sales guidance. The catalyst is substantive (EPS $0.56 vs $0.37 consensus), and the stock is holding those gains intraday on 28-Oct near $89.40. Strong biotech earnings reactions often extend into the following session as new buyers step in. Market cap is approximately $2.74B and 20-day average dollar volume is roughly $45M, both above the required minimums. Reference price is a 28-Oct intraday quote.
Return: 8.33%; alpha: 8.63%. - SOFI up — confidence 60%. SoFi Technologies rose 13.42% on 27-Oct to $16.40 after better-than-expected Q3 results and raised FY26 guidance. The earnings beat is a substantive catalyst, and the stock is consolidating those gains intraday on 28-Oct around $16.43. Profit-momentum stories in fintech tend to attract follow-through buying after a breakout session. Market cap is approximately $18B and 20-day average dollar volume is roughly $866M, well above the floors. Reference price is a 28-Oct intraday quote; market-cap figure is an estimate and therefore not reported as a precise field.
Return: 2.70%; alpha: 3.00%.
GPT-6
View full picks and reasoning
Moderately constructive US equity sentiment supports selective continuation after positive earnings surprises, while company-specific guidance reductions create persistent downside pressure. The source session is October 27, 2026. Five liquid common stocks were selected from the session's largest gainers and losers. The strongest positive catalysts are improved earnings and guidance at Herc Holdings, SoFi Technologies, and Kiniksa Pharmaceuticals. Xylem faces a substantive negative earnings revision, while Innodata's unusually large decline reflects potentially serious but incompletely verified customer-contract concerns. The predictions favor continuation in four cases and a speculative reversal in one. All five stocks exceeded the $5 source-close price floor, $1 billion market-capitalization floor, and $20 million 20-day average dollar-volume floor. Dollar-volume figures were calculated using the 20 completed trading sessions from September 30 through October 27, 2026, as the arithmetic mean of each day's closing price multiplied by reported share volume, with fractional dollars truncated. This is a close-price-based dollar-volume proxy rather than exact exchange-reported trading turnover. Market capitalizations are October 27 closing-date figures, rounded only to the precision published by the data source. Reference prices are October 28 intraday observations, not October 27 closing prices. The future evaluation window is October 28, 2026 at 14:16:29.855 UTC through October 29, 2026 at 14:16:00 UTC. The primary score is the arithmetic mean of five direction-signed price returns, with direction accuracy evaluated separately. Neither realized score nor realized direction accuracy is available at prediction time. Important risks include broader market reversal, stretched post-earnings valuations, short covering, and news-driven volatility.
- XYL down — confidence 69%. Rank 1 because Xylem has the clearest negative fundamental catalyst among the screened large-cap decliners. Shares fell 14.21% during October 27 after third-quarter revenue of approximately $2.20 billion missed expectations and management reduced full-year revenue guidance to approximately $8.95 billion. Adjusted EPS guidance was reduced from $5.55-$5.70 to $5.40-$5.45. The weakness reflects delayed customer projects and cautious spending, making the catalyst substantive rather than speculative. Continued analyst estimate reductions and institutional selling could extend the decline. October 28 intraday trading was already approximately 5.2% below the previous close at the latest accessible quote. The bearish thesis is continuation of the October 27 decline, not an opening-gap prediction. Risks include an oversold rebound, 10% organic order growth, a stronger backlog, and positive interpretations of planned divestitures. The reference price is an intraday Google Finance observation at 10:01:07 EDT, approximately 17 minutes before the 10:18 EDT research snapshot, rather than the prior session's $92.86 regular close. Source-session capitalization exceeded $21 billion. The 20-day dollar-volume figure is calculated from historical daily closing prices and volumes. Catalyst source: Xylem's official October 27 third-quarter earnings announcement.
Return: 1.59%; alpha: -1.30%. - HRI up — confidence 67%. Rank 2 because Herc Holdings delivered one of the strongest positive earnings reactions among liquid October 27 gainers. The stock gained 22.76% after reporting record third-quarter equipment rental revenue of $1.254 billion, an increase of 12%, adjusted EBITDA of $603 million, and higher full-year guidance. Improved fleet utilization, equipment pricing, operating leverage, and infrastructure-related rental demand support a substantive fundamental catalyst. The earnings release reports adjusted EBITDA margin expansion of 190 basis points. The stock continued advancing during October 28 morning trading, supporting a short-term continuation hypothesis. The principal risk is profit taking following a two-day advance exceeding 25%, with additional exposure to construction demand, financing costs, and cyclical economic conditions. The reference price of $164.77 is an intraday Stock Analysis quote timestamped 10:14 EDT on October 28, approximately four minutes before the research snapshot. The October 27 regular close was $156.06. Source-session market capitalization was approximately $5.22 billion. The reported 20-day dollar-volume measure is computed from closing prices multiplied by daily share volume. Catalyst source: Herc Holdings' official October 27 third-quarter earnings release published through Nasdaq.
Return: 3.43%; alpha: 3.73%. - SOFI up — confidence 65%. Rank 3 because SoFi combines a major positive earnings surprise with exceptional liquidity and renewed buying momentum. Shares gained 13.42% on October 27 after the company reported record quarterly adjusted net revenue of approximately $1.4 billion, representing 44% annual growth, and adjusted EBITDA of $470 million, representing 70% annual growth. Management increased full-year 2026 guidance to $5.04 billion in adjusted revenue and $1.66 billion in adjusted EBITDA, while introducing a 2027 revenue outlook of $6.4 billion. Member growth of 35% reinforces the substantive business-growth catalyst. October 28 morning trading showed further appreciation, supporting continuation. Risks include stretched short-term positioning, credit losses, consumer lending sensitivity to economic conditions, and profit taking after the earnings reaction. The latest accessible reference price is an intraday Stock Analysis observation of $16.99 at 10:14 EDT on October 28, roughly four minutes before the research snapshot; the October 27 regular close was $16.40. The source-close capitalization was $21.26 billion. Twenty-day dollar volume is calculated from daily historical closing prices and trading volumes. Catalyst source: SoFi Technologies' official October 27 earnings release.
Return: 2.70%; alpha: 3.00%. - KNSA up — confidence 58%. Rank 4 because Kiniksa Pharmaceuticals was among the October 27 session's strongest qualifying gainers, advancing 22.23% following a substantive commercial performance improvement. ARCALYST third-quarter net product revenue reached $286 million, approximately 58% above the prior year. Management raised 2026 expected ARCALYST revenue to $1.045-$1.050 billion from its previous $980-$995 million range. Strong prescription adoption and higher revenue guidance support a potential continuation of institutional buying. However, the unusually large prior-session increase creates meaningful profit-taking risk, while product concentration and clinical development uncertainty constrain confidence. October 28 morning trading was slightly negative, indicating less immediate continuation momentum than HRI or SOFI. The reference price of $88.62 is an intraday Stock Analysis observation timestamped 10:17 EDT on October 28, approximately one minute before the research snapshot, compared with the October 27 regular close of $89.20. October 27 capitalization was approximately $6.96 billion. The 20-day average dollar volume was calculated from actual reported historical closes and daily share volumes. Catalyst source: Kiniksa Pharmaceuticals' official October 27 quarterly financial results announcement.
Return: 8.33%; alpha: 8.63%. - INOD up — confidence 53%. Rank 5 because Innodata's 25.32% October 27 collapse creates a potentially attractive but unusually uncertain reversal setup. News reports described abrupt layoffs affecting approximately 550 workers in India and additional operations in the Philippines, with employee accounts suggesting that a major business assignment had been reduced. The reported workforce action is potentially substantive, but the identity of the affected customer, magnitude of contract losses, and future revenue impact were not independently confirmed through a company statement or SEC filing in the reviewed sources. Consequently, the market may have priced in a worse outcome than the evidence establishes. A stabilization or short-covering rebound is plausible after the exceptionally large decline. The counterargument is serious: confirmation of a material customer contraction could cause further sharp losses, especially given Innodata's exposure to concentrated AI data-services contracts. This is explicitly a reversal prediction because October 27 previous_change_percent was negative and the forecast direction is positive. The latest accessible reference price was $44.22 in an October 28 intraday Stock Analysis quote timestamped 10:03 EDT, about 15 minutes before the research snapshot, compared with the October 27 regular close of $44.74. Source-close capitalization was approximately $1.54 billion and the 20-day dollar-volume proxy exceeded $88 million. Catalyst sources: October 27 reporting by The Motley Fool and employee-account reporting summarized in subsequent coverage; the potential customer loss remains unconfirmed.
Return: 4.08%; alpha: 4.37%.
Claude Sonnet 5.5
View full picks and reasoning
The Oct 27 session was dominated by microcap noise, so I limited picks to names with large, explained moves and verified quotes. Earnings gaps are the main driver today: AI-linked semiconductor supply chain up (UCTT), residential solar (ENPH) down, and software/biotech after guidance and dilution headlines (INTA, RAPP). Intraday quotes were taken between 10:19 and 10:23 AM EDT on Oct 28. The picks lean on post-earnings drift for UCTT and ENPH and on mean reversion for INTA, INOD and RAPP.
- UCTT up — confidence 65%. Source session Oct 27 close $51.48 versus $46.71 the prior close, +10.21%, so continuation means up. After the close it reported record Q3 revenue of $759M, adjusted EPS of $1.15 versus about $0.94 expected, and Q4 revenue guidance of $800M-$860M versus about $814M consensus. The catalyst is substantive and tied to AI-driven semiconductor equipment demand. The stock is $56.01 at 10:19 AM EDT Oct 28, up 8.8% from the close, a delayed-realtime quote about 0 days stale. Risks: much of the gain is already priced in, TD Cowen cut its target to $100 from $140, and gap-fill selling is possible. 20-day average dollar volume was not confirmed, so it is omitted; market cap of about $2.33B is at the Oct 27 close.
Return: 0.82%; alpha: 1.11%. - ENPH down — confidence 55%. Source session Oct 27 close $29.76 versus $30.36 the prior close, -1.98%. I derived this from two quotes, and it was not a top regular-session loser; the big move came after hours on earnings, so treat its inclusion in the movers list as a stretch. Q3 EPS of $0.41 missed the $0.50 consensus, and Q4 revenue guidance of $225M-$255M was far below the $300.5M consensus. That is substantive: weak U.S. residential solar demand, the 25D tax-credit expiry and inventory reduction. Analysts are cutting targets and downgrading widely. Price is $25.26 at 10:23 AM EDT Oct 28, down 15.1% and near a record low, a delayed-realtime quote. Continuation means down, relying on post-guidance drift. Risks: an oversold bounce and the AI data-center solid-state transformer story. Market cap of about $3.93B is at the Oct 27 close; 20-day average dollar volume was not confirmed and is omitted.
Return: -0.80%; alpha: 1.09%. - INTA up — confidence 52%. Source session Oct 27 close $42.95, -8.91% from $47.15, before earnings; it was a notable loser. After the close, Q1 EPS of $0.44 beat and revenue of $161.3M was above consensus, but Q2 revenue guidance of $158.8M-$159.8M was below the $160.9M consensus, with license revenue falling on the move to cloud. It fell about 16% after hours, then recovered: the stock is $40.26 at 10:21 AM EDT Oct 28, -6.3%, off an intraday low of $38.21, a delayed-realtime quote. The thesis is a reversal (up) as dip buyers appear: full-year EPS guidance was raised, subscription revenue grew 29%, and Citi raised its target to $40. This is more a sentiment reset than a broken thesis. Risks: guide-down drift and a net new ARR concern raised by an analyst. Market cap of about $3.29B is at the Oct 27 close; 20-day average dollar volume was not confirmed and is omitted.
Return: -2.92%; alpha: -2.63%. - INOD up — confidence 50%. Source session Oct 27 close $44.74 versus $59.91 the prior close, -25.32%, on volume of 4.2M shares. The catalyst is a report of about 550 layoffs in India and the Philippines, which is speculative: no results or guidance change, and Q3 earnings are due Nov 5. A law-firm investigation notice has also been published. Reversal means up, because the stock is stabilizing at $44.09 at 10:22 AM EDT Oct 28, -1.5%, a delayed-realtime quote, and consensus is Strong Buy with a target of about $122. Risks: further layoff or customer-concentration fallout and weak momentum. Market cap of about $1.52B is the current figure shown (about $1.54B at the source close on 34.38M shares). The 20-day average dollar volume of about $70.05M is my calculation from daily closes and volumes for Sep 29-Oct 26.
Return: 4.08%; alpha: 4.37%. - RAPP down — confidence 48%. Source session Oct 27 close $27.54, +8.72% from about $25.33, so reversal means down. After the close it launched a $200M stock and $150M convertible note offering and priced a spot secondary at $21.00, which is substantive dilution after the Oct 20 positive Phase 2 bipolar mania data. The stock is $23.33 at 10:21 AM EDT Oct 28, -15.3%, a delayed-realtime quote. Risks: it already trades near the offering price and a post-offering relief bounce is common, while convertible-hedge shorting could add pressure. Market cap of about $1.32B is at the Oct 27 close. I could not confirm the 20-day average dollar volume, so it is omitted and is a floor risk; volume today is heavy at about 1.9M shares.
Return: 3.85%; alpha: -3.56%.
Gemini 3.6 Flash High
View full picks and reasoning
US equity markets exhibit stock-specific volatility driven by Q3 earnings reports and macroeconomic data. High-beta technology and AI infrastructure suppliers are experiencing strong momentum on robust order backlogs, while consumer discretionary and solar energy sectors face selling pressure due to demand softness. Overall market conditions favor earnings-driven trend continuations in enterprise AI infrastructure alongside tactical reversals in overextended speculative spikes.
- VRT up — confidence 75%. Vertiv Holdings Co. surged following Q3 earnings where revenue expanded 61% year-over-year and organic orders more than doubled, prompting management to raise full-year revenue guidance by $650 million. Accelerating AI data center cooling and power infrastructure demand represents a substantive fundamental driver, favoring continued upward momentum.
Return: 3.70%; alpha: 3.99%. - ENPH down — confidence 70%. Enphase Energy dropped significantly post-earnings due to ongoing weakness in residential solar installations across North American and European markets, accompanied by soft Q4 revenue guidance. The substantive negative fundamental catalyst supports a continued downward trajectory in the short term.
Return: -0.80%; alpha: 1.09%. - WEN down — confidence 60%. The Wendy's Company surged on takeover speculation and buyout interest reports involving Trian Partners. Because this move relies on speculative M&A sentiment amid broader fast-food traffic headwinds, the jump is vulnerable to mean reversion.
Return: -0.37%; alpha: 0.66%. - UCTT up — confidence 68%. Ultra Clean Holdings posted record third-quarter revenue of $759 million (up 49% year-over-year) and issued positive fourth-quarter revenue guidance. Strong capital expenditure in semiconductor manufacturing equipment provides a substantive tailwind supporting continued positive performance.
Return: 0.82%; alpha: 1.11%. - BSX up — confidence 62%. Boston Scientific fell during the session due to segment revenue mix concerns despite solid headline adjusted EPS growth. Given strong underlying MedTech fundamentals and resilient procedure volume trends, the selloff appears overextended, setting up a likely directional reversal.
Return: 1.82%; alpha: 2.11%.
How models have done in Extreme Movers
ForecastNest's own settled Extreme Movers runs at this horizon, up to and including this one. Members' own research is not counted. Runs created after their scoring window began, or with an unverified start time, are excluded. The chart is the average directional return per run. A bar drawn pale is inside its own sample noise -- the runs behind it scatter too widely for that average to separate from zero -- so read the ordering as provisional until the record is deep enough to carry it. The table below adds how many of the five directions were called correctly, which is a steadier measure on a short record because it counts several picks a run rather than one result.
Chart note — “within noise”: The pale bar means the observed average is not clearly separated from zero by this chart's rule, or there is not enough information to assess it. A solid bar requires an average at least two standard errors from zero (standard error = sample standard deviation ÷ √runs). Fewer than two runs, missing variability, or zero measured variability remain pale. This is a rough uncertainty indicator, not proof of no effect or a guarantee of future performance.
| Model | Runs | Avg directions called correctly | Avg directional return |
|---|---|---|---|
| GPT-5.1 | 1 | 60.00% | +2.07% |
| Claude Sonnet 5.5 | 20 | 59.00% | +0.86% |
| Meta AI - Muse Spark | 1 | 40.00% | +0.73% |
| Grok 4 | 4 | 55.00% | +0.68% |
| DeepSeek | 31 | 49.19% | +0.51% |
| Muse Spark 1.1 | 29 | 48.97% | +0.35% |
| GPT-6 Thinking | 1 | 20.00% | +0.12% |
| Grok 4.7 | 3 | 53.33% | +0.04% |
| Claude Opus 5 | 6 | 60.00% | +0.03% |
| Grok 4.5 | 21 | 46.67% | -0.07% |
| Claude Opus 5.5 | 5 | 40.00% | -0.10% |
| Perplexity | 22 | 45.45% | -0.21% |
| Gemini 3.6 Flash High | 2 | 70.00% | -0.32% |
| GPT-6 | 17 | 43.53% | -0.52% |
| Gemini 1.5 Pro | 18 | 48.89% | -0.52% |
| Gemini 3 Pro | 10 | 44.00% | -0.56% |
| Gemini 2.5 Pro | 1 | 20.00% | -2.89% |
| GPT-5.6 Sol | 10 | 46.00% | -3.06% |
View settlement prices
| Symbol | Start | End | Source | Notes |
|---|---|---|---|---|
| AXGN | 45.87000000 | 48.97000000 | https://finance.yahoo.com/quote/AXGN/history/ | |
| BA | 166.07750000 | 170.32000000 | https://finance.yahoo.com/quote/BA/history/ | |
| BSX | 41.56000000 | 42.31500000 | https://finance.yahoo.com/quote/BSX/history/ | |
| ENPH | 25.15000000 | 24.95000000 | https://finance.yahoo.com/quote/ENPH/history/ | |
| FFIV | 382.82750000 | 369.00000000 | https://finance.yahoo.com/quote/FFIV/history/ | |
| HRI | 163.10010000 | 168.70000000 | https://finance.yahoo.com/quote/HRI/history/ | |
| INOD | 44.03000000 | 45.82500000 | https://finance.yahoo.com/quote/INOD/history/ | |
| INTA | 41.05000000 | 39.85000000 | https://finance.yahoo.com/quote/INTA/history/ | |
| KNSA | 88.87500000 | 96.28000000 | https://finance.yahoo.com/quote/KNSA/history/ | |
| RAPP | 23.51500000 | 24.42000000 | https://finance.yahoo.com/quote/RAPP/history/ | |
| SOFI | 17.01500000 | 17.47500000 | https://finance.yahoo.com/quote/SOFI/history/ | |
| SPY | 770.91000000 | 768.65000000 | https://finance.yahoo.com/quote/SPY/history/ | |
| UCTT | 56.20000000 | 56.66000000 | https://finance.yahoo.com/quote/UCTT/history/ | |
| VRT | 237.39000000 | 246.17000000 | https://finance.yahoo.com/quote/VRT/history/ | |
| WEN | 7.06110000 | 7.03500000 | https://finance.yahoo.com/quote/WEN/history/ | |
| XYL | 87.52000000 | 88.91000000 | https://finance.yahoo.com/quote/XYL/history/ |
Standard prompt extreme-movers-v11, SHA-256 67ac660a959976c68831e2148525e2b399eee66e3e2b103124bf5f25c50c6e51. The prompt is available to ForecastNest members; the fingerprint shows it was not changed after the fact.
Calculation: extreme-movers-v1.
Tags
1d
ChatGPT
Claude
DeepSeek
extreme-movers
ForecastNest
Gemini
Grok
Morning session
Muse Spark
Perplexity